A multi-center study of therapeutic efficacy and safety of platelet components prepared with pathogen inactivation (INTERCEPT) stored for 6 or 7 days prior to transfusion
Vox Sanguinis. 2010;99((Suppl S1):):13.
Study Details
| Study Design: | Randomised Controlled Trial |
|---|